The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJEO.L Regulatory News (JEO)

  • There is currently no data for JEO

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half Yearly Report

21 Feb 2017 17:20

RNS Number : 4798X
Jupiter European Opps. Trust PLC
21 February 2017
 

Jupiter European Opportunities Trust PLC

 

Half Yearly Financial Report for the six months to 30 November 2016 (unaudited)

 

Financial Highlights

 

Capital Performance

 

 

30 November

2016

31 May

2016

% change

Total assets less current liabilities (£'000)

619,154

613,922

+0.9

 

Ordinary Share Performance

 

 

30 November

2016

31 May

2016

% change

Net asset value (pence)

554.92

550.23

+0.9

Net asset value total return (pence)

560.42

554.03

+1.2

Middle market price (pence)

523.75

530.00

-1.2

FTSE World Europe ex UK Total Return Index*

1,083.76

977.23

+10.90

Discount to net asset value (%)

(5.6)

(3.7)

-

Ongoing charges figure (%)

1.10

1.08

-

 

 

* This document contains information based on the FTSE World Europe ex UK Total Return Index. 'FTSE®' is a trade mark owned by the London Stock Exchange Plc and is used by FTSE International Limited ('FTSE') under licence. The FTSE World Europe ex UK Total Return Index is calculated by FTSE. FTSE does not sponsor, endorse or promote the product referred to in this document and is not in any way connected to it and does not accept any liability in relation to its issue, operation and trading. All copyright and database rights in the index values and constituent list vest in FTSE. 

 

Performance since launch

 

 

 

 

Year-

 

 

 

 

on-year

 

 

 

Net Asset

change in

Year-

 

Total Assets

Value

Net Asset

on-year

 

less

per

Value per

change in

 

Current

Ordinary

Ordinary

Benchmark

 

Liabilities

Share

Share

Index

Year ended 31 May

£'000

p

%

%

20 November 2000 (launch)

93,969

94.66

-

-

2001

83,600

89.29

-5.7

-8.0

2002

91,028

91.12

+2.0

-10.7

2003

84,592

83.82

-8.0

-19.0

2004

97,915

109.25

+30.3

+15.7

2005 (restated)***

117,679

133.54

+22.2

+19.3

2006

154,927

167.47

+25.4

+26.2

2007

182,278

224.58

+34.1

+30.0

2008

188,519

230.56

+2.7

-0.1

2009

131,457

162.35

-29.6

-25.3

2010

185,504

232.40

+43.1

+14.4

2011

252,813

316.73

+36.3

+24.2

2012

231,584

291.05

-8.1

-24.2

2013

340,801

403.58

+38.7

+43.3

2014

409,191

451.26

+11.8

+13.4

2015

558,389

546.27

+21.1

+4.7

2016

613,922

550.23

+0.7

-3.7

30 November 2016

619,154

554.92

+0.9

+10.9

 

***Prior to 2005, financial information was prepared under UK GAAP. From 2006 all information is prepared under IFRS.

 

 

 

Chairman's Statement

 

Over the six months to 30 November 2016 the Net Asset Value per share of your Company rose by 1.2 per cent. This performance was behind the return on the Company's benchmark, the FTSE World Europe ex UK Total Return Index, which increased by 10.9 per cent. over the same period.

 

Since the end of November 2016 the Net Asset Value per share has increased by 5.8 per cent. to 592.83 pence (as at 31 January 2017), which compares with a return of 7.7 per cent. for the benchmark over the same period.

 

The background to your Company's recent underperformance is considered in depth by our portfolio manager, Alexander Darwall, in his Investment Adviser's report below and I will not seek to cover the same ground here except to observe that your Company has experienced similar periods of underperformance in earlier investment cycles. Nevertheless, it is pertinent to note that the return on the net asset value per share of your Company has significantly outperformed the Company's benchmark over three and five years. Since the Company's launch in November 2000 the total return on the net asset value per share, with dividends reinvested on their payment dates, has been 603.7 per cent. (as at 30 November 2016), which compares with a total return of 120.0 per cent. by the Company's benchmark over the same period.

 

Gearing

 

At the end of the period under review the gearing level on the Company's investment portfolio had increased to 15 per cent.

 

Our portfolio manager tends to increase gearing at times of perceived low valuations, while reducing it as markets recover. This approach has added sustained value over the course of your Company's history and we continue to encourage the portfolio manager to consider the use of gearing as a tactical tool to improve returns.

 

Outlook

 

All companies in our investment universe have to face the challenges arising from technological advances, changing fashion, the rising tide of regulation, and other developments too numerous to mention. Some will adapt successfully, and their shareholders will be amply rewarded for backing them. Others, lacking the necessary vision to override such challenges, will fail. Your manager seeks to identify successful managements, in a variety of different spheres, ahead of the majority of investors. Success is not guaranteed; but the long term record speaks for itself.

 

Hugh Priestley

Chairman

21 February 2017

 

Investment Adviser's Review

 

Performance was poor in the period under review. Whilst the FTSE World Europe ex UK Total Return Index, your Company's benchmark, rose by 10.9 per cent., Sterling adjusted, the Net Asset Value of the Company's Ordinary shares returned 1.2 per cent. during the six months to 30 November 2016. The Company's total borrowings rose during the period under review to £106.4m at 30 November, representing gearing of 15 per cent.

 

The FTSE World Index was up by 20.8 per cent., Sterling adjusted, a better performance than Europe largely because America's S&P 500 Index was up 23.1 per cent. Other markets advanced strongly. The MSCI Latin America Index was 34.1 per cent. higher; the MSCI AC Asia ex-Japan Index was up by 25.8 per cent.; and the Japanese Nikkei 225 Index advanced by 20.8 per cent.

 

Whilst the obvious explanation for the relatively disappointing performance of the European equity markets is political events - the European Union (EU) crisis and the perceived threat of the new US Administration - the real explanation lies in Europe's economic policies. The core of the policy is Quantitative Easing, a cheap money policy. The European Central Bank's (ECB) main refinancing rate was reduced to 0 per cent. early in 2016. It is questionable whether this, together with a marked reluctance to reform the labour markets, is a successful policy. Growth rates remain low in Europe. The International Monetary Fund's latest forecasts (October 2016) are for 1.9 per cent. growth in the EU in 2016 and 1.7 per cent. in 2017; they forecast 3.1 per cent. and 3.4 per cent. world growth in 2016 and 2017 respectively. Clearly Europe is falling behind. Corporate borrowing growth has been moderate as companies are reluctant to commit more capital in Europe. As far as the banks are concerned there is a further challenge. More companies are going directly to the capital markets for funding, disintermediating the banks.

 

The macro backdrop neither explains nor excuses investment performance. Sector weightings, the underweight positions in oil and gas, basic materials and to a lesser extent financials all penalised performance and partly explain the outcome. But as always stock selection is the key. We aim to identify companies that should benefit from 'super-macro' drivers: regulatory changes, technology developments, changes in consumer or customer behaviour, or a shifting competitive landscape. We seek evidence that these drivers have indeed started to unlock multi-year, 'micro' opportunities for a given company. When we are correct these drivers can override the impact of macro factors. Equally, where we suffer reverses it is usually because our analysis of these drivers was mistaken.

 

Although the list of 'winners' is an eclectic one with a huge diversity of activities, we can identify which of the drivers explains success. Thus Marine Harvest, the largest salmon farming company in the world, is clearly a beneficiary of changing consumer habits, in this case increasing consumption of salmon in the West; BioMerieux, a French diagnostics company, is enjoying a technological advantage over its competitors; and RELX, the Anglo-Dutch provider of information and risk analytics, benefits from its use of digital technology and regulatory changes. Amadeus, another 'winner', is using its industry leading technology in airline bookings to develop in the hotel booking segment.

 

Of the underperforming stocks there is a distinction to be made between those where we have concerns and those where we don't. The biggest single negative impact was NovoNordisk: we are concerned. Our confidence in robust US pricing for their insulin products was misplaced. The shock of NovoNordisk's near term challenges has caused us to reconsider our investment. We have concluded that there are many reasons why we believe that the company has good prospects: the development of a new class of drug to treat diabetes, steady demand growth, and scope for innovation and differentiation.

 

For these and other reasons we have retained a significant position. Ingenico and Novozymes also detracted significantly from performance. The former, a world leader in the electronic payments business, has suffered from a slowdown in growth in the US. We consider their problems to be temporary rather than structural. In fact we believe that new opportunities for Ingenico present themselves in countries like India where the authorities are encouraging electronic money transactions. We have therefore maintained our investment. The growth rate at Novozymes has declined. The company's prospects appear to be to a certain extent dependent on energy prices. We are reviewing this position. Amongst the other notable underperformers were Grenke and ALK Abello. Neither of these gives us cause for concern. Both companies continue to generate good profits growth and we remain encouraged by their prospects. Inmarsat was another disappointing performer. In both its maritime and aviation operations the news flow has as yet failed to justify management's bullish assertions. The coming months are critical in seeing whether or not this optimism is well founded.

 

Of the outright sales, ARM Holdings was sold following an offer to purchase the company. Leonteq too was sold. Only a 1.4 per cent. position at peak this was sold as we lost confidence in the management's ability to grow the business. Autoliv, another small holding, was sold as we considered that there were better ways to profit from the substantial innovation in the automotive sector. Instead we initiated a position in Umicore, a global materials technology and recycling group. Its rechargeable battery materials put it in a leading place to benefit from the development of electrification of cars. This was one of only a few new positions and none was big. The largest new investment was that of Edenred, constituting barely 1 per cent. of the portfolio at the period end. Edenred is the world leader in prepaid corporate services. These services include government funded benefits and corporate expense management mainly in Europe and Brazil. Under new management we consider that the company will extend its reach, benefitting from digital technology. We added to existing holdings in Syngenta (because there was substantial upside assuming that the bid goes through as agreed). Of particular note was the substantial addition to the holding in Carnival. A good industry structure combined with growing demand for cruising, especially in China, should lead to healthy profits growth.

The political and other macro events in 2016 presage great changes. Further upheavals in Europe can reasonably be expected in 2017. Yet we do not anticipate what those changes will be. It is too soon to tell. There will be challenges and opportunities. Our strategy remains entirely consistent, focusing on individual company opportunities which can prosper in a range of macro-economic scenarios. Correctly identifying 'winners' from the range of 'drivers', as described above, should shape prospects for your Company more than macro vicissitudes. In any case, the broad geographic exposure of 'our' companies operating across the world mitigates much of the regional macro risk. We remain confident that plenty of good investment opportunities exist and that our process for identifying such opportunities is an appropriate one.

 

Alexander Darwall

Fund Manager

Jupiter Asset Management Limited

21 February 2017

 

Investment Portfolio as at 30 November 2016

 

 

 

30 November 2016

31 May 2016

 

 

Market

Percentage

Market

Percentage

 

 

value

of

value

of

Company

Country of Listing

£'000

portfolio

£'000

portfolio

Syngenta

Switzerland

63,813

8.8

54,524

7.7

Wirecard

Germany

57,368

7.9

46,812

6.6

RELX

Netherlands

54,872

7.6

48,733

6.9

Provident Financial

UK

50,978

7.0

48,015

6.8

Novo Nordisk

Denmark

47,682

6.6

62,788

8.9

Inmarsat

UK

42,722

5.9

33,427

4.7

Deutsche Börse

Germany

39,652

5.5

31,779

4.5

Amadeus

Spain

37,526

5.2

31,316

4.4

Fresenius

Germany

37,019

5.1

33,418

4.7

Experian

UK

35,124

4.9

30,355

4.3

Carnival

UK

27,061

3.7

6,028

0.9

Grenke

Germany

26,650

3.7

31,659

4.5

Ryanair

Ireland

18,302

2.5

16,732

2.4

Grifols

Spain

16,807

2.3

16,658

2.4

Ingenico

France

16,214

2.2

21,703

3.1

BioMerieux

France

14,652

2.0

6,729

0.9

Novozymes

Denmark

14,254

2.0

45,999

6.6

Coloplast

Denmark

13,238

1.8

18,953

2.7

Royal Caribbean

Cruises

Liberia

12,125

1.7

9,944

1.4

Dassault Systemes

France

9,567

1.3

8,511

1.2

Luxottica Group

Italy

8,887

1.2

10,957

1.5

Intrum Justitia

Sweden

8,502

1.2

6,015

0.8

Worldpay Group

UK

7,833

1.1

8,063

1.1

ALK-Abello

Denmark

7,826

1.1

7,666

1.1

Arrow Global Group

UK

7,756

1.1

1,398

0.2

Edenred

France

7,661

1.1

-

-

Gemalto

Netherlands

6,740

0.9

2,310

0.3

Saga

UK

5,362

0.7

8,740

1.2

Lonza Group

Switzerland

4,991

0.7

2,963

0.4

Marine Harvest

Norway

4,694

0.7

14,305

2.0

KWS Saat

Germany

4,588

0.6

4,494

0.6

Essilor International

France

3,349

0.5

4,486

0.6

Umicore

Belgium

2,880

0.4

2,598

0.4

Genus

UK

2,812

0.4

-

-

Ossur

Denmark

1,944

0.3

1,836

0.3

Elementis

UK

1,550

0.2

4,003

0.6

Alfa Laval

Sweden

602

0.1

-

-

Total

 

723,603

100.0

 

 

 

Cross Holdings in other Investment Companies

 

As at 30 November 2016 and 31 May 2016, none of the Company's assets were invested in the securities of other listed closed-ended investment companies. It is the Company's stated policy that it will not invest in other listed closed-ended investment companies.

 

Interim Management Report

 

Related Party Transactions

 

During the first six months of the current financial year no transactions with related parties have taken place which have materially affected the financial position or performance of the Company. Details of related party transactions are contained in the Annual Report and Accounts of the Company for the year ended 31 May 2016.

 

Principal Risks and Uncertainties

 

The Company is exposed to the effect of variations in the price of its investments. A fall in the value of its portfolio will have an adverse effect on Shareholders' funds. It is not the aim of the Board to eliminate entirely the risk of capital loss, rather it is its aim to seek capital growth. Other key risks faced by the Company relate to foreign currency movements, interest rates, liquidity risk, gearing risk, the discount to Net Asset Value, regulatory risk, loss of key personnel, operational and financial risks. A detailed explanation of the Risks and Uncertainties facing the Company can be found in the Annual Report and Accounts for the year ended 31 May 2016.

 

Going Concern

 

The Half Yearly Financial Report has been prepared on a going concern basis. The Directors consider that this is the appropriate basis as they have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future. In considering this, the Directors took into account the Company's investment objective, risk management policies and capital management policies, the diversified portfolio of readily realisable securities which can be used to meet short-term funding commitments and the ability of the Company to meet all of its liabilities and ongoing expenses. Thus the Directors continue to adopt the going concern basis of accounting in preparing the financial statements.

 

Directors' Responsibility Statement

 

We, the Directors of Jupiter European Opportunities Trust PLC, confirm to the best of our knowledge that:

 

(a) The condensed set of financial statements have been prepared in accordance with the Accounting Standards Board's statement 'Half-Yearly Financial Reports' and give a true and fair view of the assets, liabilities, financial position and profit of the Company for the period ended 30 November 2016;

 

(b) The Chairman's Statement, the Investment Adviser's Review and the Interim Management Report include a fair review of the information required by Disclosure and Transparency Rule 4.2.7R; and

 

(c) The Interim Management Report includes a fair review of the information required by Disclosure and Transparency Rule 4.2.8R on related party transactions.

 

The Half Yearly Financial Report has not been audited or reviewed by the Company's auditors.

 

By Order of the Board

 

H M Priestley

Chairman

21 February 2017

 

 

Statement of Comprehensive Income

 

For the six months to 30 November 2016 (unaudited)

 

 

30 November 2016

30 November 2015

Revenue

Capital

Total

Revenue

Capital

Total

 

£'000

£'000

£'000

£'000

£'000

£'000

Gain on investments at fair

 

 

 

 

 

 

value through profit or loss

-

15,048

15,048

-

30,701

30,701

Foreign exchange (loss)/gain on loan

-

(5,676)

(5,676)

-

1,218

 1,218

Currency exchange gain/(loss)

-

354

354

-

(108)

(108)

Income

4,703

-

4,703

3,161

-

3,161

Total income

4,703

9,726

14,429

3,161

31,811

34,972

Investment management fee

(2,823)

-

(2,823)

(2,455)

-

(2,455)

Investment performance fee

-

(23)

(23)

-

(8,806)

(8,806)

Other expenses

(316)

-

(316)

(327)

-

(327)

Total expenses

(3,139)

(23)

(3,162)

(2,782)

(8,806)

(11,588)

Net return before finance costs and taxation

1,564

9,703

11,267

379

23,005

23,384

Finance costs

(475)

-

(475)

(286)

-

(286)

Return before taxation

1,089

9,703

10,792

93

23,005

23,098

Taxation

(475)

-

571

198

-

198

Net return after taxation

1,660

9,703

11,363

291

23,005

23,296

Return per Ordinary share

1.49p

8.70p

10.19p

0.27p

21.57p

21.84p

 

The total column of this statement is the income statement of the Company prepared in accordance with International Financial Reporting Standards (IFRS). The supplementary revenue return and capital return columns are both prepared under guidance produced by the Association of Investment Companies (AIC).

 

All items in the above statement derive from continuing operations.

 

The return after taxation is also the total comprehensive profit for the year.

 

All income is attributable to the equity holders of Jupiter European Opportunities Trust PLC.

 

The financial information does not constitute 'accounts' as defined in section 434 of the Companies Act 2006.

 

 

Statement of Financial Position

 

As at 30 November 2016

 

 

30 November

31 May

 

2016

2016

 

(unaudited)

(audited)

 

£'000

£'000

Non current assets

 

 

Investments held at fair value through profit or loss

723,603

707,402

Current assets

 

 

Other receivables

5,331

4,279

Cash and cash equivalents

4,517

6,091

 

9,848

10,370

Total assets

733,451

717,772

Current liabilities

 

 

Other payables

(114,297)

(103,850)

Total net assets less current liabilities

619,154

613,922

Capital and reserves

 

 

Called up share capital

1,116

1,116

Share premium

193,561

193,555

Special reserve

33,687

33,687

Capital redemption reserve

45

45

Retained earnings

390,745

385,519

Total equity shareholders' funds

619,154

613,922

Net Asset Value per Ordinary share

554.92p

550.23p

 

 

Statement of Changes in Equity

 

For the six months to 30 November 2016

 

 

 

 

 

Capital

 

 

 

Share

Share

Special

Redemption

Retained

 

For the six months toCapitalPremiumReserveEarningsEarningsTotal

30 November 2016 (unaudited)

£'000

£'000

£'000

£'000

£'000

£'000

Balance at 1 June 2016

1,116

193,555

33,687

45

385,519

613,922

Net profit for the period

-

-

-

-

11,363

11,363

Ordinary shares issue

-

6

-

-

-

6

Dividends declared

-

-

-

-

(6,137)

(6,137)

Balance at 30 November 2016

1,116

193,561

33,687

45

390,745

619,154

 

 

 

 

 

 

 

 

 

 

 

Capital

 

 

 

Share

Share

Special

Redemption

Retained

 

For the six months to

Capital

Premium

Reserve

Reserve

Earnings

Total

30 November 2015 (unaudited)

£'000

£'000

£'000

£'000

£'000

£'000

Balance at 1 June 2015

1,022

142,988

33,687

45

380,647

558,389

Net profit for the period

-

-

-

-

23,296

23,296

Ordinary shares issue

66

34,683

-

-

-

34,749

Dividends declared and paid *

-

-

-

-

(4,133)

(4,133)

Balance at 30 November 2015

1,088

177,671

33,687

45

399,810

612,301

 

* Dividends paid during the period were paid out of revenue reserves.

 

Cash Flow Statement

 

For the six months to 30 November 2016 (unaudited)

 

 

2016

2015

 

£'000

£'000

Cash flows from operating activities

 

 

Investment income received (gross)

6,605

4,633

Investment management fee paid

(2,794)

(2,317)

Investment performance fee paid

(5,325)

(12,609)

Other cash expenses

(308)

(307)

Net cash outflow from operating activities before taxation and interest

(1,822)

(10,600)

Interest paid

(418)

(218)

Taxation

262

232

Net cash outflow from operating activities

(1,978)

(10,586)

Cash flows from investing activities

 

 

Purchases of investments

(95,078)

(98,961)

Sales of investments

91,298

52,126

Net cash outflow from investing activities

(3,780)

(46,835)

Cash flows from financing activities

 

 

Ordinary shares issued

6

34,749

Net drawdown of loan

3,824

24,847

Net cash inflow from financing activities

3,830

59,596

(Decrease)/increase in cash

(1,928)

2,175

Cash and cash equivalents at start of period

6,091

5,669

Realised gain/(loss) on foreign currency

354

(108)

Cash and cash equivalents at end of period

4,517

7,736

 

 

Notes to the Financial Statements

 

1. Accounting Policies

The Accounts comprise the unaudited financial results of the Company for the period to 30 November 2016. The Accounts are presented in pounds Sterling, as this is the functional currency of the Company.

 

The Accounts have been prepared in accordance with International Financial Reporting Standards (IFRS), which comprise standards and interpretations approved by the International Accounting Standards Board (IASB) and International Accounting Standards Committee (IASC), as adopted by the European Union (EU). Where presentational guidance set out in the Statement of Recommended Practice (SORP) for Investment Trusts issued by the Association of Investment Companies (AIC) in November 2014 is consistent with the requirements of IFRS, the Directors have sought to prepare the financial statements on a basis compliant with the recommendations of the SORP.

 

The Company continues to adopt the going concern basis in the preparation of the financial statements.

 

2. Gains on investments

 

 

Six months to

Six months to

 

30 November 2016

30 November 2015

 

£'000

£'000

Net gain realised on sale of investments

28,054

19,196

Movement in unrealised (losses)/gains

(13,006)

11,505

Gains on investments

15,048

30,701

 

3. Return per Ordinary share

 

 

Six months to

Six months to

 

30 November 2016

30 November 2015

 

£'000

£'000

Net revenue profit

1,660

291

Net capital profit

9,703

23,005

Net total profit

11,363

23,296

Weighted average number of Ordinary

 

 

shares in issue during the period

111,575,331

106,657,219

Revenue earnings per Ordinary share (p)

1.49

0.27

Capital return per Ordinary share (p)

8.70

21.57

Total return per Ordinary share (p)

10.19

21.84

 

4. Net Asset Value per Ordinary share

The Net Asset Value per Ordinary share is based on the net assets attributable to the Ordinary shareholders of £619,154,000 (31 May 2016: £613,922,000) and on 111,575,331 (31 May 2016: 111,575,331) Ordinary shares, being the number of Ordinary shares in issue at the period end.

 

 

5. Related Parties

Jupiter Unit Trust Managers Limited ('JUTM'), the Alternative Investment Fund Manager, is a company within the same group as Jupiter Asset Management Limited, the Investment Adviser. JUTM receives investment management fees as set out below.

 

JUTM is contracted to provide investment management services to the Company (subject to termination by not less than twelve months' notice by either party) for an annual fee of 0.75 per cent. of the net assets of the Company after deduction of the value of any Jupiter managed investments, payable quarterly in arrears.

 

The management fee payable to JUTM for the period 1 June 2016 to 30 November 2016 was £2,823,000 (31 May 2016: £5,102,000) with £1,372,000 (31 May 2016: £1,343,000) outstanding at period end.

 

JUTM is also entitled to an investment performance fee which is based on the out-performance of the Net Asset Value per Ordinary share over the total return on the Benchmark Index, the FTSE World Europe ex UK Total Return Index, in an accounting period. Any performance fee payable will equal 15 per cent. of the amount by which the increase in the Net Asset Value per Ordinary share (plus any dividends per Ordinary share paid or payable and any accrual for unpaid performance fees for the period) exceeds the higher of (a) the Net Asset Value per Ordinary share on the last business day of the previous accounting period; (b) the Net Asset Value per Ordinary share on the last day of a period in respect of which a performance fee was last paid: and (c) 100p. In each case the values of (a), (b) and (c) are increased by the percentage by which the total return of the Benchmark Index increases or decreases during the calculation period. The total amount of any performance fee payable in respect of one accounting period is limited to 4.99 per cent. of the Total Assets of the Company. No performance fee is payable in respect of the period under review.

 

The Company has invested from time to time in funds managed by Jupiter Investment Management Group Limited or its subsidiaries. There was no such holding as at 30 November 2016 (31 May 2016: Nil). No investment management fee is payable by the Company to Jupiter Asset Management Limited in respect of the Company's holdings in investment trusts, open-ended funds and investment companies in respect of which Jupiter Investment Management Group Limited, or any subsidiary undertaking of Jupiter Investment Management Group Limited, receives fees as investment manager or investment adviser.

 

A copy of the Half-Yearly Financial Report will shortly be available for download from the Company's website www.jupiteram.com/JEO

 

For further information, please contact:

 

Richard Pavry

Head of Investment Trusts

Jupiter Asset Management Limited, Company Secretary

investmentcompanies@jupiteram.com

 

020 3817 1496

 

21 February 2017

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR PGUQGPUPMGMG
Date   Source Headline
23rd Nov 202110:14 amRNSNet Asset Value(s)
23rd Nov 20217:00 amRNSChange of TIDM
22nd Nov 202110:18 amRNSNet Asset Value(s)
19th Nov 20215:09 pmRNSTransaction in Own Shares
19th Nov 20219:11 amRNSNet Asset Value(s)
18th Nov 20219:27 amRNSNet Asset Value(s)
17th Nov 20214:50 pmRNSHolding(s) in Company
17th Nov 20219:26 amRNSNet Asset Value(s)
16th Nov 20219:35 amRNSNet Asset Value(s)
15th Nov 20215:14 pmRNSTransaction in Own Shares
15th Nov 20218:58 amRNSNet Asset Value(s)
12th Nov 202111:08 amRNSNet Asset Value(s)
11th Nov 20215:14 pmRNSTransaction in Own Shares
11th Nov 20219:07 amRNSNet Asset Value(s)
10th Nov 202111:58 amRNSResult of AGM/Final Dividend/Director Retirement
10th Nov 202111:51 amRNSHolding(s) in Company
10th Nov 20219:20 amRNSNet Asset Value(s)
9th Nov 20215:49 pmRNSHolding(s) in Company
9th Nov 20215:30 pmRNSTransaction in Own Shares
9th Nov 20219:33 amRNSNet Asset Value(s)
8th Nov 20215:23 pmRNSTransaction in Own Shares
8th Nov 20212:52 pmRNSHolding(s) in Company
8th Nov 20219:37 amRNSNet Asset Value(s)
5th Nov 20215:27 pmRNSTransaction in Own Shares
5th Nov 202110:57 amRNSHolding(s) in Company
5th Nov 20219:51 amRNSNet Asset Value(s)
4th Nov 20215:20 pmRNSTransaction in Own Shares
4th Nov 20219:26 amRNSNet Asset Value(s)
3rd Nov 20219:38 amRNSNet Asset Value(s)
2nd Nov 202111:33 amRNSPortfolio Update
2nd Nov 20219:31 amRNSNet Asset Value(s)
1st Nov 20214:51 pmRNSHolding(s) in Company
1st Nov 202110:23 amRNSNet Asset Value(s)
29th Oct 20215:47 pmRNSTotal Voting Rights
29th Oct 20215:38 pmRNSTransaction in Own Shares
29th Oct 20219:24 amRNSNet Asset Value(s)
28th Oct 20215:36 pmRNSTransaction in Own Shares
28th Oct 20219:53 amRNSNet Asset Value(s)
27th Oct 20215:31 pmRNSTransaction in Own Shares
27th Oct 202110:46 amRNSNet Asset Value(s)
26th Oct 202110:10 amRNSNet Asset Value(s)
25th Oct 202111:28 amRNSNet Asset Value(s)
22nd Oct 20215:41 pmRNSTransaction in Own Shares
22nd Oct 20219:17 amRNSNet Asset Value(s)
21st Oct 20215:09 pmRNSTransaction in Own Shares
21st Oct 20219:21 amRNSNet Asset Value(s)
20th Oct 20219:31 amRNSNet Asset Value(s)
19th Oct 20219:50 amRNSNet Asset Value(s)
18th Oct 20219:57 amRNSNet Asset Value(s)
15th Oct 20215:23 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.